Abstract
Precision medicine is a revolutionary approach to disease prevention and treatment that takes into account individual differences in lifestyle, environment, and biology. Precision medicine will give clinicians tools to better understand the complex mechanisms underlying a person's health, disease, or condition, and to better predict which treatments and prevention strategies will be most effective. Spearheaded by the National Institutes of Health, the All of Us Research Program seeks to engage one million or more volunteers living in the U.S. to contribute their health data over many years to improve health outcomes, fuel the development of new treatments for disease, and catalyze a new era of evidence-based and more precise preventive care and medical treatment. By taking part, participants will contribute to an effort to advance the health of generations to come. As promising as the concept of precision medicine truly is if we are to truly change the treatment paradigm and ensure that the medicines and prevention strategies people are using actually work for them, those who have traditionally been under-represented in research need to participate. These conversations are not easy and will take purposeful time and effort to build trust toward action—we need precision engagement. This talk will provide an overview of the All of Us Research Program and its goals; outline the All of Us transformational approach to diversity, participation, and data access; and describe the program's approach to precision engagement to address value and build trust.
Citation Format: Dara Richardson-Heron. The All of Us Research Program and precision engagement [abstract]. In: Proceedings of the Eleventh AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2018 Nov 2-5; New Orleans, LA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2020;29(6 Suppl):Abstract nr IA03.
RSS Feeds